Document is current
Any future updates will be listed below
-
Authors
Pompili, Maurizio
Berardelli, Isabella
Erbuto, Denise
Caraci, Filippo
- License Information
-
More Information
Article History
Received: 24 December 2024
Accepted: 11 February 2025
First Online: 17 March 2025
Change Date: 22 March 2025
Change Type: Update
Change Details: The original online version of this article was revised: The error in the article title has been corrected
Declarations
:
: N/A.
: The authors declare no conflicts of interest. Prof. M Pompili wishes to disclose that in the last five years, has received lectures and advisory board honoraria or has engaged in clinical trial activities with Angelini Pharma, Allergan, Janssen, Lundbeck, Merck Sharp and Dohme, Otsuka, Rovi, Pfizer Inc, Fidia, Viatris, Recordati, Boehringer Ingelheim, Newron, GSK, Neopharmed Gentili, and Teva, all of which are unrelated to this article.
